Dicerna Pharmaceuticals, Inc Earning Date (DRNA)

USA |NASDAQ |USD

DRNA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 23, 2022 Dec 2021 $-0.54 $-0.22 $-0.49
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 23, 2022 Dec 2021 $41.27M $62.95M $40.96M

Dicerna Pharmaceuticals, Inc's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 2021.

DRNA Earnings Date & History Chart

DRNA Earnings & Revenue Forecast

DRNA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 6 $-0.67 $-0.92 $-0.27
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 9 $-2.00 $-3.88 $-0.41

DRNA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $-0.67 $-0.62 $-0.56
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-2.00 $-1.43 $-1.50

DRNA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 5 $34.01M $15.10M $50.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 9 $191.11M $50.60M $332.20M

DRNA Earnings Date & Revenue History

DRNA Earnings History

|
Show More
Show More

DRNA Revenue History

|
Show More
Show More

Dicerna Pharmaceuticals, Inc Next Earnings Date & Report

DRNA Next Earnings Date & Report Preview: Dec 2021 (FQ)

DRNA's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 8 analysts, the average EPS estimation for Dicerna Pharmaceuticals, Inc's next quarterly earnings is $-0.54, with a low EPS estimation of $-0.99, and a high estimation of $-0.04.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.54, the last 2 month trend is $-0.41, and the 3 month trend is $-0.41.

Based on 8 analysts, the average revenue estimation is $41.27M, with a low revenue estimation of $6.50M, and a high estimation of $92.60M.

Dicerna Pharmaceuticals, Inc Previous Earnings Dates & Reports

DRNA Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Dicerna Pharmaceuticals, Inc's previous earnings date was Nov 9, 2021 for its fiscal quarter ended Sep 30, 2021.

DRNA's earnings per share (EPS) was $-0.22, beating the consensus analysts forecast of $-0.50 by 56.01%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -58.49%, and higher than the same period a year before (Sep 2020) by -24.14%.

Revenues were $62.95M, better than the forecast of $43.78M by 43.80%, up by 52.29% from the previous quarter , and up by 28.81% from the same period last year.

The company reported a net income of $-17.07M.

Free cash flow for the quarter was $-63.80M , compared to $153.99M last quarter and $-61.15M a year before.

DRNA ended the quarter with $64.42M in total debt, a decrease of -1.12% compared to the previous quarter, and an increase of 198.41% compared to the same quarter a year before.

DRNA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Dicerna Pharmaceuticals, Inc's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

DRNA's earnings per share (EPS) was $-1.52, missing the consensus analysts forecast of $-1.05 by 44.76% , and higher than the previous year's EPS (Dec 2019) by -13.64%.

Revenues were $164.31M, worse than the forecast of $190.56M by -13.78%, and up by 587.36% from previous year's revenue.

The company reported a net income of $-112.75M.

Dicerna Pharmaceuticals, Inc reported a free cash flow of $163.37M for its fiscal year, compared to $-7.04M a year ago.

The company ended the fiscal year with $52.18M in total debt, an increase of 122.06% compared to the previous year.